Milestone Scientific (MLSS) Competitors $0.63 0.00 (-0.67%) As of 10:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLSS vs. CV, CVRX, SGHT, TLSI, INGN, PROF, ELMD, RCEL, LNSR, and PDEXShould you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include CapsoVision (CV), CVRx (CVRX), Sight Sciences (SGHT), TriSalus Life Sciences (TLSI), Inogen (INGN), Profound Medical (PROF), Electromed (ELMD), Avita Medical (RCEL), LENSAR (LNSR), and Pro-Dex (PDEX). These companies are all part of the "medical equipment" industry. Milestone Scientific vs. Its Competitors CapsoVision CVRx Sight Sciences TriSalus Life Sciences Inogen Profound Medical Electromed Avita Medical LENSAR Pro-Dex Milestone Scientific (NYSE:MLSS) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends. Does the media favor MLSS or CV? In the previous week, Milestone Scientific had 1 more articles in the media than CapsoVision. MarketBeat recorded 1 mentions for Milestone Scientific and 0 mentions for CapsoVision. Milestone Scientific's average media sentiment score of 0.00 equaled CapsoVision'saverage media sentiment score. Company Overall Sentiment Milestone Scientific Neutral CapsoVision Neutral Do analysts recommend MLSS or CV? Milestone Scientific presently has a consensus target price of $1.25, indicating a potential upside of 99.68%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than CapsoVision.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00CapsoVision 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders believe in MLSS or CV? 5.8% of Milestone Scientific shares are owned by institutional investors. 24.8% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is MLSS or CV more profitable? CapsoVision has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. CapsoVision's return on equity of 0.00% beat Milestone Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Milestone Scientific-52.01% -60.26% -40.23% CapsoVision N/A N/A N/A Which has better valuation & earnings, MLSS or CV? CapsoVision has higher revenue and earnings than Milestone Scientific. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMilestone Scientific$8.61M5.70-$6.93M-$0.07-8.94CapsoVision$12.04M16.43N/AN/AN/A SummaryMilestone Scientific beats CapsoVision on 6 of the 11 factors compared between the two stocks. Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLSS vs. The Competition Export to ExcelMetricMilestone ScientificSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$49.13M$27.25M$5.56B$20.75BDividend YieldN/AN/A4.00%3.65%P/E Ratio-8.9412.8328.4127.54Price / Sales5.702.26439.7552.98Price / CashN/A12.8024.9917.94Price / Book5.692.208.224.61Net Income-$6.93M-$5.31M$3.24B$993.55M7 Day Performance-2.64%-0.78%3.04%1.32%1 Month Performance-28.77%-9.56%8.77%6.78%1 Year Performance-27.54%-16.10%33.62%10.99% Milestone Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLSSMilestone Scientific2.6877 of 5 stars$0.63-0.7%$1.25+99.7%-25.9%$49.13M$8.61M-8.9430CVCapsoVisionN/A$4.37-4.4%N/AN/A$202.51MN/A0.0090Gap DownCVRXCVRx3.1047 of 5 stars$7.35+7.6%$14.50+97.3%-11.4%$191.64M$52.87M-3.37160Positive NewsSGHTSight Sciences1.5753 of 5 stars$3.70+8.5%$4.10+10.8%-54.9%$191.28M$78.11M-3.78210TLSITriSalus Life Sciences2.0784 of 5 stars$4.98+1.8%$10.75+115.9%-17.7%$188.44M$32.14M-4.45106Gap DownINGNInogen4.1979 of 5 stars$6.71-3.0%$11.00+63.9%-32.0%$180.41M$339.96M-5.831,030PROFProfound Medical2.1331 of 5 stars$5.75-1.0%$11.50+100.0%-45.7%$172.79M$10.68M-4.71150Positive NewsELMDElectromed0.9644 of 5 stars$19.30+1.2%$38.00+96.9%+15.2%$161.85M$61.44M25.73160Analyst ForecastRCELAvita Medical0.892 of 5 stars$5.88+3.2%$16.50+180.6%-46.1%$155.41M$64.25M-2.68130Gap UpLNSRLENSAR1.235 of 5 stars$12.90-1.0%$15.00+16.3%+170.7%$152.09M$53.49M-2.66110Positive NewsPDEXPro-Dex1.9175 of 5 stars$46.23+2.7%$56.00+21.1%+138.1%$150.71M$53.84M16.51140High Trading Volume Related Companies and Tools Related Companies CapsoVision Alternatives CVRx Alternatives Sight Sciences Alternatives TriSalus Life Sciences Alternatives Inogen Alternatives Profound Medical Alternatives Electromed Alternatives Avita Medical Alternatives LENSAR Alternatives Pro-Dex Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MLSS) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredI want to be your mentorAnnouncing: Larry Benedict's "Market Wizard Protégé Program" (not suited for everyone) Larry Benedict has cre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLSS Stock Alerts